The FDA's New Psychedelic Rules Are Groovy, but the Agency Is Still a Bad Trip
The new rules will fast track clinical testing, but a far cry from legalization or decriminalization.
Original Source
Read the full article at Reason →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.